Ralph Brasacchio
Concepts (110)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Brachytherapy | 10 | 1999 | 32 |
Why?
|
Radiotherapy, Computer-Assisted | 2 | 2006 | 9 |
Why?
|
Prosthesis Implantation | 4 | 2006 | 23 |
Why?
|
Prostatic Neoplasms | 10 | 1999 | 120 |
Why?
|
Robotics | 4 | 2005 | 21 |
Why?
|
Ultrasonography, Interventional | 3 | 1999 | 32 |
Why?
|
Needles | 5 | 2006 | 24 |
Why?
|
Radiology, Interventional | 1 | 2006 | 7 |
Why?
|
Carcinoma | 1 | 2006 | 109 |
Why?
|
Prostate | 4 | 1999 | 55 |
Why?
|
Algorithms | 3 | 1999 | 226 |
Why?
|
Complementary Therapies | 1 | 2011 | 23 |
Why?
|
Radiotherapy Dosage | 3 | 1999 | 55 |
Why?
|
Fatigue | 1 | 2011 | 48 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 1999 | 20 |
Why?
|
Equipment Design | 2 | 2006 | 132 |
Why?
|
Melena | 1 | 2006 | 6 |
Why?
|
Pentosan Sulfuric Polyester | 1 | 2006 | 3 |
Why?
|
Proctitis | 1 | 2006 | 4 |
Why?
|
Humans | 16 | 1998 | 1856 |
Why?
|
Neoplasms, Second Primary | 1 | 2008 | 31 |
Why?
|
Diarrhea | 1 | 2006 | 41 |
Why?
|
Micromanipulation | 1 | 2006 | 11 |
Why?
|
Bone Neoplasms | 2 | 2004 | 83 |
Why?
|
Surgical Instruments | 1 | 2006 | 35 |
Why?
|
Equipment Failure Analysis | 1 | 2006 | 44 |
Why?
|
Male | 12 | 1998 | 1553 |
Why?
|
Neoplasm Metastasis | 1 | 2006 | 112 |
Why?
|
Surgical Procedures, Operative | 1 | 2006 | 77 |
Why?
|
Radiation Injuries | 1 | 2006 | 63 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 78 |
Why?
|
Breast Neoplasms | 1 | 2011 | 185 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2003 | 14 |
Why?
|
Postoperative Care | 1 | 2003 | 84 |
Why?
|
Imaging, Three-Dimensional | 1 | 2003 | 58 |
Why?
|
Pubic Bone | 1 | 2001 | 7 |
Why?
|
Stress, Mechanical | 3 | 2006 | 93 |
Why?
|
Models, Biological | 1 | 2006 | 410 |
Why?
|
Radiotherapy, Conformal | 1 | 1999 | 12 |
Why?
|
Lung Neoplasms | 3 | 2004 | 159 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 1998 | 49 |
Why?
|
Motion | 2 | 2006 | 23 |
Why?
|
Tomography, X-Ray Computed | 1 | 2001 | 321 |
Why?
|
Hodgkin Disease | 1 | 1998 | 46 |
Why?
|
Liver Neoplasms | 2 | 2004 | 97 |
Why?
|
Neoplasm Staging | 2 | 2004 | 125 |
Why?
|
Aged | 4 | 2001 | 988 |
Why?
|
Middle Aged | 4 | 2001 | 1161 |
Why?
|
Feasibility Studies | 2 | 1999 | 144 |
Why?
|
Brain Neoplasms | 2 | 2004 | 116 |
Why?
|
Massage | 1 | 2011 | 9 |
Why?
|
Energy Metabolism | 1 | 2011 | 80 |
Why?
|
Pilot Projects | 1 | 2011 | 264 |
Why?
|
Abdominal Neoplasms | 1 | 2008 | 20 |
Why?
|
Adenoma | 1 | 2008 | 46 |
Why?
|
Pituitary Neoplasms | 1 | 2008 | 25 |
Why?
|
Carcinoid Tumor | 1 | 2008 | 20 |
Why?
|
Aged, 80 and over | 2 | 2004 | 599 |
Why?
|
Quality of Life | 1 | 2011 | 188 |
Why?
|
Treatment Outcome | 2 | 2004 | 661 |
Why?
|
Stereotaxic Techniques | 1 | 2006 | 24 |
Why?
|
Hardness | 1 | 2006 | 15 |
Why?
|
Injections | 1 | 2006 | 53 |
Why?
|
Morbidity | 1 | 2006 | 62 |
Why?
|
Whole-Body Irradiation | 1 | 2006 | 43 |
Why?
|
Placebos | 1 | 2006 | 110 |
Why?
|
Administration, Oral | 1 | 2006 | 170 |
Why?
|
Adenocarcinoma | 1 | 2008 | 167 |
Why?
|
Orchiectomy | 1 | 2004 | 23 |
Why?
|
Computer Simulation | 1 | 2006 | 134 |
Why?
|
Risk Assessment | 1 | 2008 | 324 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2004 | 30 |
Why?
|
Pattern Recognition, Automated | 1 | 2003 | 19 |
Why?
|
Radiometry | 1 | 2003 | 31 |
Why?
|
Tumor Markers, Biological | 1 | 2006 | 112 |
Why?
|
Female | 3 | 1998 | 1643 |
Why?
|
Androgen Antagonists | 1 | 2004 | 18 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 431 |
Why?
|
Phantoms, Imaging | 1 | 2003 | 41 |
Why?
|
Kinetics | 1 | 2006 | 349 |
Why?
|
Severity of Illness Index | 1 | 2006 | 358 |
Why?
|
Cost Savings | 1 | 2001 | 16 |
Why?
|
Survival Rate | 1 | 2004 | 250 |
Why?
|
Risk Factors | 1 | 2008 | 555 |
Why?
|
Decision Theory | 1 | 1999 | 5 |
Why?
|
Palladium | 1 | 1999 | 10 |
Why?
|
Intraoperative Period | 1 | 1999 | 43 |
Why?
|
Physics | 1 | 1999 | 8 |
Why?
|
Physical Phenomena | 1 | 1999 | 8 |
Why?
|
Iodine Radioisotopes | 1 | 1999 | 64 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 37 |
Why?
|
Ultrasonography | 1 | 2001 | 89 |
Why?
|
Carmustine | 1 | 1998 | 25 |
Why?
|
Neoplasms | 1 | 2006 | 239 |
Why?
|
Radiotherapy, Adjuvant | 1 | 1998 | 49 |
Why?
|
Models, Genetic | 1 | 1999 | 90 |
Why?
|
Etoposide | 1 | 1998 | 37 |
Why?
|
Cytarabine | 1 | 1998 | 32 |
Why?
|
Transplantation, Autologous | 1 | 1998 | 78 |
Why?
|
Disease-Free Survival | 1 | 1998 | 102 |
Why?
|
Adult | 2 | 1998 | 1317 |
Why?
|
Cyclophosphamide | 1 | 1998 | 82 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 427 |
Why?
|
Retrospective Studies | 1 | 2004 | 653 |
Why?
|
Decision Making | 1 | 1999 | 130 |
Why?
|
Combined Modality Therapy | 1 | 1998 | 219 |
Why?
|
Recurrence | 1 | 1998 | 261 |
Why?
|
Prognosis | 1 | 1998 | 388 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 1998 | 121 |
Why?
|
Follow-Up Studies | 1 | 1998 | 553 |
Why?
|
